BioCentury
ARTICLE | Company News

Affectis, Grupo Uriach deal

January 29, 2007 8:00 AM UTC

Grupo Uriach's Palau Pharma subsidiary granted Affectis an exclusive worldwide license to cimicoxib to treat all CNS indications except pain. Affectis will develop the COX-2 inhibitor to treat depres...